Abiopharma

News list

FDA approves RYBREVANT FASPRO from JANSSEN BIOTECH

FDA Approval
Dec. 31, 2025, 13:45 UTC

Final approval of BLA #BLA #761433 for AMIVANTAMAB AND HYALURONIDASE-LPUJ. Decision date: 12/17/2025

Full text

Register to leave comments
There are no comments here yet...